A Study of SGN-ALPV in Advanced Solid Tumors

Clinical trial NCT05229900 · TERMINATED

Trial details

NCT number: NCT05229900
Sponsor: Seagen Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Neoplasms Endometrial Neoplasms Carcinoma, Non-Small-Cell Lung Stomach Neoplasms Gastroesophageal Junction Carcinoma Uterine Cervical Neoplasms Testicular Neoplasms

Start date: 2022-04-21
Primary completion: 2023-12-13
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.